Human Drugs View

Product Information BR-1125_PI_01.pdf
Registration Number BR-1125
Generic Name Quadrivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) Southern Hemisphere 2024 Strain.
Brand Name Fluarix Tetra
Dosage Strength Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, IVR-237) B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) [Yamagata lineage] *Propagated in embryonated chicken eggs **Haemagglutinin 15 μg of HA** 15 μg of HA** 15 μg of HA** 15 μg of HA**
Dosage Form Suspension for Injection (IM)
Classification Prescription Drug (RX)
Pharmacologic Category Vaccines
Packaging 0.5 mL in 1 mL Type I pre-filled glass syringe with luer lock adapter and plastic rigid tip cap (PRTC) and 2 separate needles (25G 5/8" and 25G 1") in a plastic tray (Box of 1's).
Manufacturer GlaxoSmithKline Biologicals NL Der SmithKline
Country of Origin Germany
Trader
Importer GlaxoSmithKline Philippines, Inc.
Distributor GlaxoSmithKline Philippines, Inc.
Application Type Monitored Release (Strain Clearance)
Issuance Date 19 February 2024
Expiry Date 19 February 2025